Alleo Labs
PrivateLast Round
Accelerator
Mar 26, 2025
Company Overview
Alleo Labs operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in March 2025.
Alleo Labs is a biotechnology company that develops precision therapeutics for neurological diseases such as Parkinson's and Alzheimer's using machine learning and computational biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alleo Labs Comparables
Compare Alleo Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brenig Therapeutics | 84% | |
| Mission Therapeutics | 78% | |
| Insitro | 76% |
For institutional investors. Book with your work email.
Alleo Labs Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alleo Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Toronto Asset Management Corporation | Accelerator |
| The Termeer Institute | Accelerator |
| Creative Destruction Lab | Accelerator |
| Netherlands Organization for Scientific Research | Grant |
| Nvidia Inception | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors grew 94% MoM, from 619 to 1.2K.
For institutional investors. Book with your work email.
Alleo Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alleo Labs's valuation, stock price, and market status.
Is Alleo Labs a public or private company?
Alleo Labs is a private company.
What is the current stock price of Alleo Labs?
Alleo Labs is a private company, so its shares have no public market price. Caplight tracks Alleo Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alleo Labs worth (valuation)?
Valuation information for Alleo Labs is not publicly available.
Can I buy Alleo Labs stock?
Alleo Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alleo Labs's last funding round?
Alleo Labs's most recent funding round was Accelerator on March 26, 2025.
Who are the main investors in Alleo Labs?
Key investors in Alleo Labs include University of Toronto Asset Management Corporation, The Termeer Institute, Creative Destruction Lab, Netherlands Organization for Scientific Research, Nvidia Inception.
Will Alleo Labs IPO soon?
No public IPO plans have been announced for Alleo Labs.
How can I track Alleo Labs secondary market activity?
Caplight tracks bids, offers, and trades in Alleo Labs's shares on secondary markets.